TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Amphastar Pharmaceuticals, Inc. (AMPH)

Healthcare Drug Manufacturers - Specialty & Generic
20.20 $
+1.4% vs. previous close
Closing price · As of: 3. Aug 2026

Amphastar Pharmaceuticals, Inc. (AMPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 1,648 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet AMPH
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
1,378 1,545 1,513 1,574 1,492 1,545 1,577 1,626 1,615 1,666 1,629 1,648
385 543 490 555 483 546 534 588 581 639 636 634
151 267 144 201 190 192 152 183 188 217 170 171
168 300 257 290 218 250 222 237 232 279 283 294
105 119 115 139 132 145 138 145 135 147 144 148
105 110 106 115 122 130 154 185 192 186 177 170
279 – – – – – – – – – – –
3.2 3.1 3.2 3.2 3.1 3.3 3.0 3.2 3.4 3.4 3.4 3.3
622 616 610 604 598 592 588 581 575 569 563 556
789 949 873 902 778 818 845 875 858 889 840 875
251 258 225 255 137 159 174 199 176 205 158 164
16 4.2 4.3 4.4 4.2 4.5 7.0 8.0 8.8 8.8 9.6 11
19 32 25 37 32 34 31 53 42 41 33 36
488 638 590 594 587 596 602 604 608 609 609 610
589 595 639 672 713 728 732 751 757 777 789 773
324 373 409 452 490 531 569 594 625 642 667 673
53 54 53 53 52 52 52 50 48 48 47 46

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?